Neuroglee secures $10m funding to advance home-based Alzheimer's treatment

Openspace Ventures led the Series A round. 

Neuroglee Therapeutics, which builds personalised evidence-based digital therapeutics (DTx) and virtual care solutions to treat and manage patients with neurodegenerative diseases, has closed a $10m Series A funding round last 9 September.

The funding injection will enable Neuroglee to launch pioneering virtual neurology clinics for patients diagnosed with mild cognitive impairment related to difficult-to-treat conditions such as Alzheimer's disease, whilst advancing the company's DTx pipeline.

According to Neuroglee Founder and CEO Aniket Singh Rajput, "This funding will be instrumental in facilitating the continued development of Neuroglee's digital therapeutics and virtual clinical services, which combines cognitive rehabilitation strategies and remote care management to help delay or slow the worsening of symptoms in patients with mild cognitive impairment due to Alzheimer’s disease."

Neuroglee and Mayo Clinic are co-developing Neuroglee Connect, a novel clinical care program based on Mayo Clinic's Healthy Action to Benefit Independence & Thinking (HABIT). HABIT is a 10-day in-person program to provide patients and their families with state-of-the-art, evidence-based lifestyle and behavioural treatments for mild cognitive impairment.

Openspace Ventures led the round with participation from EDBI, Mudipharma former CEO Raman Singh, Biofourmis co-founders Kuldeep Singh Rajput and Wendou Niu, and pharmaceutical company Eisai Co.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

A white paper recommends a new model for healthcare delivery and financing.
Two companies have bid to make the hospital group private.
The move aims to provide world-class critical care for India.
The two will create a regional and international hub for non-invasive diagnostics in Singapore.
The institute aims to serve as a maternal and child health research centre.
Remote clinics rely heavily on irregular mobile medical services.
The products are part of the Heart Wellness Check-Up programme launched in Bangkok.
But, the companies can decide not to push through with the plan.
The report also shows maintenance cost of equipment has exceeded the cost of new procurement.
The partnership will enable high-potential research on cancer immunotherapy in Asia Pacific.
Bayer held the #TakeControl virtual roundtable on the occasion of World Contraception Day 2021.
This will establish a smart platform for advanced medical treatment.
They are the 35- to 54-year-old adults caring for both parents and children.
Around 66% of Southeast Asians preferring remote video-call consultations with medical professionals.